Literature DB >> 15904976

Microglia activation in rat spinal cord by systemic injection of TLR3 and TLR7/8 agonists.

Zhiren Zhang1, Katrin Trautmann, Hermann J Schluesener.   

Abstract

Here we describe activation of microglia in the rat spinal cord by systemic injections of toll-like receptor agonist polyinosine-polycytidylic acid (poly(I:C), a TLR3 ligand) and R848 (a TLR 7/8 ligand). A significant but transient increase of ED-1+ spinal cord microglia was observed 4 days after a single intraperitoneal (i.p.) injection. Immunostainings by different microglial markers, AIF-1, EMAPII, OX6, P2X(4) receptor (P2X4R), indicated that microglia were not fully activated and tracing of cell proliferation by 5-bromo-2 -deoxyuridine revealed that only a small fraction of proliferating cells were microglia (less than 5%). Thus, these stimulators of the innate immune system have, after peripheral administration, clearly effects on the innate immune system of the spinal cord. This should be considered in the design of clinical trials, as both TLR ligands have been used in patients. As injections of TLR ligands can be used to modulate immune activity in the spinal cord, such agents might be tools to modulate local regenerative processes in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15904976     DOI: 10.1016/j.jneuroim.2005.03.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

Review 1.  Toll-like receptors in chronic pain.

Authors:  Lauren Nicotra; Lisa C Loram; Linda R Watkins; Mark R Hutchinson
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

Review 2.  Toll-like receptors in defense and damage of the central nervous system.

Authors:  Rajagopal N Aravalli; Phillip K Peterson; James R Lokensgard
Journal:  J Neuroimmune Pharmacol       Date:  2007-04-03       Impact factor: 4.147

Review 3.  In-depth conversation: spectrum and kinetics of neuroimmune afferent pathways.

Authors:  Ning Quan
Journal:  Brain Behav Immun       Date:  2014-02-22       Impact factor: 7.217

Review 4.  Maternal immune activation and abnormal brain development across CNS disorders.

Authors:  Irene Knuesel; Laurie Chicha; Markus Britschgi; Scott A Schobel; Michael Bodmer; Jessica A Hellings; Stephen Toovey; Eric P Prinssen
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

5.  Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.

Authors:  Niranjan B Butchi; Min Du; Karin E Peterson
Journal:  Glia       Date:  2010-04-15       Impact factor: 7.452

Review 6.  Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.

Authors:  Mark L Hanke; Tammy Kielian
Journal:  Clin Sci (Lond)       Date:  2011-11       Impact factor: 6.124

7.  Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.

Authors:  Li-Jin Chew; Paolo Fusar-Poli; Thomas Schmitz
Journal:  Dev Neurosci       Date:  2013-02-27       Impact factor: 2.984

8.  Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals.

Authors:  Jill S Cameron; Lena Alexopoulou; Jacob A Sloane; Allitia B DiBernardo; Yinghua Ma; Bela Kosaras; Richard Flavell; Stephen M Strittmatter; Joseph Volpe; Richard Sidman; Timothy Vartanian
Journal:  J Neurosci       Date:  2007-11-21       Impact factor: 6.167

Review 9.  Pattern recognition receptors and central nervous system repair.

Authors:  Kristina A Kigerl; Juan Pablo de Rivero Vaccari; W Dalton Dietrich; Phillip G Popovich; Robert W Keane
Journal:  Exp Neurol       Date:  2014-08       Impact factor: 5.330

Review 10.  From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma.

Authors:  David Križaj; Daniel A Ryskamp; Ning Tian; Gülgün Tezel; Claire H Mitchell; Vladlen Z Slepak; Valery I Shestopalov
Journal:  Curr Eye Res       Date:  2013-10-21       Impact factor: 2.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.